Uteroglobin

DB14880Investigational

Uteroglobin is under investigation in clinical trial NCT01473264 (Safety, Pk and Anti-inflammatory Effects of CC10 Protein in Premature Infants With Respiratory Distress Syndrome (RDS)).

Mechanism: Pharmacologically active on Phospholipase A2 and N-formyl peptide receptor 2
Curator reviewed

Resolves to

Compound

UNII95O4MMG4LJ

Targets

P04054PLA2G1BP25090FPR2

What you can answer from here — as of July 07, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with Uteroglobin, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account